Verrica Pharmaceuticals Statistics
NASDAQ: VRCAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.74-0.145 (-5.03%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Verrica Pharmaceuticals by the numbers
Verrica Pharmaceuticals has a market capitalization of $47.1 million based on 17.18M shares outstanding. With trailing EPS of $-2.30, Verrica Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.8% below its 50-day average and 48.3% below its 200-day average.
Average daily trading volume is 68.78K shares, or about $188,468 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VRCA valuation vs. peer median
| Metric | VRCA | Peer median | Difference |
|---|---|---|---|
| Market cap | $47.07M | $46.70M | +1% |
| Avg. volume | 68.78K | 957.84K | -93% |
Peer median across 8 companies: NMAD, ONCY, TNXP, MIST, RFL, HRTX, HOWL, RNXT.
Valuation
- Market cap
- $47.07M
- Price / sales (latest FY)
- 1.32
- EPS (TTM)
- $-2.30
- Shares outstanding
- 17.18M
Price and trading
- Previous close
- 2.89
- Open
- 2.88
- Day range
- 2.73 – 2.96
- 52-week range
- 2.73 – 9.82
- 52-week change
- -34.92%
- Beta
- —
- Volume
- 127.03K
- Average volume
- 68.78K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 47.07M
- Forward Pe
- -1.79
- Eps
- -2.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.82
- Week52 Low
- 2.73
- Avg Volume
- 68,784.00
- Shares Outstanding
- 17.18M
- Ma50
- 3.85
- Ma200
- 5.30
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -72.10%
- Pct From52w Low
- 0.37%